Skip to main content

Change location

You are currently on the USA (English) website

My country is not on the list

Global

  • Bracco.com (English)

Asia

  • China (中文)
  • Japan (日本語)
  • South Korea (한국어)

Americas

  • Brazil (Português)
  • Canada (English)
  • Mexico (English)
  • Canada (Français)
  • USA (English)

Europe

  • Austria (English)
  • Belgium (English)
  • Czech Republic (English)
  • Denmark (English)
  • Finland (English)
  • France (Français)
  • Germany (Deutsch)
  • Iceland (English)
  • Italy (Italiano)
  • Luxembourg (English)
  • Norway (English)
  • Poland (English)
  • Slovakia (English)
  • Sweden (English)
  • Switzerland (English)
  • The Netherlands (English)
  • UK (English)
  • Careers
  • Media and News
  • Get in touch
  • Product Security
  • Sign up
    • USA (English)
  • We are Bracco Diagnostics
    We are Bracco

    Welcome to a World of contrasts

    • Bracco at a glance
    • Past, present, future
    • Our Foundation
    • Our business
  • Our portfolio

    To order products go to myorders.bracco.com

    • X-ray & CT
      • Products

        • ISOVUE and Imaging Bulk Package
        • GASTROGRAFIN
        • READI-CAT 2 SMOOTHIE
        • READI-CAT 2
        • TAGITOL V
      • Fluoroscopy

        • VARIBAR
        • CYSTOGRAFIN
        • CYSTOGRAFIN-DILUTE
        • E-Z-DISK
        • E-Z-GAS II
        • E-Z-HD
        • E-Z-PAQUE
        • ENTERO VU
        • GASTROGRAFIN
        • Liquid E-Z-PAQUE
      • Myelography

        • ISOVUE-M 200/300
      • Medical devices

        • EmpowerCTA+
        • PROTOCO2L TOUCH
    • MRI
      • Contrast agents

        • Vueway (Gadopiclenol)
        • MultiHance
        • ProHance
      • Medical Devices

        • Max 3
        • EmpowerMR
      • Other

        • CitraClear™
    • Ultrasound
      • Contrast agents

        • LUMASON
    • Nuclear medicine
      • Products

        • CardioGen-82
        • HeartSee
        • Kinevac
        • Choletec
    • Cardiology
      • Contrast agents

        • CardioGen-82
        • Lumason
        • ISOVUE
        • ACIST CVi
        • Heartsee
    • Digital solutions
    • Reimbursement
    • Oncology
  • Bracco innovation—the driving force behind everything we do, building upon our unique culture of research and discovery.
    Innovation

    A deep dive into our R&D progress

    • Digital future
    • R&D
    • The Bracco sites
    • Scientific heritage
  • Knowledge header
    Knowledge

    Current activities and future opportunities

    • Educational programs
    • Partnerships and sponsorships
    • Events
  • Child walking next to plants and touching their leaves
    Sustainability

    Our game plan and goals for a better world

    • Our sustainability pillars
    • Governance and transparency
    • Sustainability report
  • Our Stories
Article
Bracco Diagnostics Inc. Branded Max 3™ received FDA 510(k) clearance Bracco Diagnostics Inc. Branded Max 3TM, a Rapid Exchange and Syringeless Injector, received FDA 510(k) clearance adding evolving innovation in Magnetic Resonance Imaging (MRI) and its product portfolio.
Max 3, a Rapid Exchange and Syringeless Injector
Page
CitraClear signup form
No image available
Article
Bracco Suisse and Verasonics: a new strategic partnership The collaboration focuses on combining Verasonics' Vantage®️ NXT Research Ultrasound Systems with Bracco's contrast agents to explore improved imaging performance in various research applications.
Verasonics logo
Article
Bracco Diagnostics Inc. Announces Update on Product Portfolio Strategic decisions enable Bracco to serve better the needs of healthcare providers and patients with its enhanced pipeline offering.
Bracco Diagnostics Inc. Announces Update on Product Portfolio
Article
Blue Earth Diagnostics appoints Marco Campione as Chief Executive Officer Mr. Campione brings more than 25 years global experience in successful development and commercialization of diagnostic imaging agents and radiopharmaceuticals.
Blue Earth Diagnostic
Article
Bracco Imaging awarded EcoVadis Gold Medal for the second time Bracco Imaging has been reconfirmed amongst the top 5% of 100,000 global companies certified by EcoVadis for the second year in a row
Ecovadis Sustainability Rating 2024 Bracco Group
Article
Join Bracco at RSNA 2024 Explore the Bracco Booth #3300 as Bracco Diagnostics Inc. showcases its innovations and more at the 2024 Radiological Society of North America Annual Congress.
Bracco at RSNA 2024 Building intelligent connections
Article
Bracco Diagnostics Inc. Introduces CitraClear™ to the Healthcare Community Bracco Diagnostics Inc. (BDI) proudly unveils CitraClearTM, a pre-procedure hydration beverage designed with patients in mind. 
CitraClear Logo
Article
Bracco Imaging and Arrayus Technologies: a new strategic partnership Bracco Imaging and Arrayus Technologies have partnered to improve drug delivery for pancreatic cancer using focused ultrasound and microbubble technology.
Bracco Arrayus partnership
Article
AI Pills in Medical Writing This webinar series, in collaboration with Springer Healthcare Italia, a global leader in healthcare education and communication, is designed to provide radiologists with practical insights into the use of innovative digital tools and technologies to improve the effectiveness of medical writing.
AI Pills in Medical Writing
  • Load More

The Bracco Group is an international group of highly specialized companies.
We are an active part of the healthcare sector, and a global leader in diagnostic imaging.

  • We are Bracco
  • Our portfolio
  • Innovation
  • Knowledge
  • Sustainability
  • Our stories
  • Pharmacovigilance
  • Data Protection

Connect with us

Via Egidio Folli 50
20134 Milan, Italy
Phone + 39 02 2177.1

  • Terms of Use
  • Privacy Policy
  • Cookie Policy
  • for Bracco VPN users

Bracco Copyright © 2025 | Registered office: Via E. Folli, 50, 20134 Milano, Italy | Share Capital € 104.000.000 f.p. | VAT Milan Comp. Reg. n. 00825120157 | Milan REA n. 348182